Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>MCL R
>
Treatment
>
Co: CN. B. Brand Zanubrutinib>
>
(*) USA Approval Date: 2019. 11.14.
(*) USA Approval Date: 2019. 11.14.'s products
This section has no products